Submitted by Anonymous (not verified) on 18 February 2026 - 10:25
Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan, Date of authorisation: 09/12/2022, Revision: 12, Status: Authorised
Source: